Liquid Biopsy Market Global Forecast by Cancer, Product, Sample, Circulating Biomarkers, Regions, Company Analysis
A liquid biopsy is an emerging tool for the diagnosis of cancer disease nowadays. The liquid biopsy involves collecting samples and analysing tumours in the blood to diagnose cancer disease in the human body. Liquid biopsy assists medical practitioners as a source of genomic and proteomic knowledge in cancer patients by early detection of circulating tumour cells, DNA and extracellular vesicles. Currently, liquid biopsy plays a critical role in accelerating and implementing accurate oncology in clinical settings by leading to an improved understanding of tumour heterogeneity and allowing for dynamic control of reactions to care and variations in genomics. According to Renub Research analysis, Global Liquid Biopsy Market is expected to be US$ 3.1 Billion by 2026.
The major growth drivers of liquid biopsies are that while extracting the tissue sample from the human body is much pain-free, it substitutes the pain associated with the procedure. Besides, liquid biopsy is very accurate in detecting tumour cells in the blood of cancer patients. Due to the low sensitivity of liquid biopsy, it acts as the restraint factor in the market’s growth.
The key players play an essential role in the liquid biopsy market’s growth by launching innovative products. In June 2020, NeoGenomics Inc. launched three liquid biopsy tests for non-small cell lung cancer, solid tumour types, and specific breast cancer. The COVID-19 effect in the liquid biopsy market has been harsh because all patients are taking therapies to treat cancer; since they have a weak immune system, and they are less prone to fight with coronavirus diseases.
The report titled “Liquid Biopsy Market Global Forecast by Cancer (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer & Others), Product (Kits & Consumables, Instruments and Services), Sample (Plasma/Serum, Urine & Others), Circulating Biomarkers (Circulating Tumor DNA (ctDNA), Circulating Tumor Cells (CTCs) & Exosomes), Clinical Application (Monitoring, Theranostics, Prognosis & Screening), Regions (Europe, North America, Latin America, Asia-Pacific and Middle East/Africa), Companies (Roche Diagnostics, Thermo Fisher Scientific Inc., Biocept Inc., Bio-Rad Laboratories Inc., Genomic Health, Biocartis, Myriad Genetics Inc., Qiagen, NeoGenomics Laboratories)” provides a detailed analysis of Global Liquid Biopsy Industry.
By Cancer 1. Lung Cancer 2. Breast Cancer 3. Colorectal Cancer 4. Prostate Cancer 5. Others
By Product 1. Kits & Consumables 2. Instruments 3. Services
By Circulating Biomarkers 1. Circulating Tumor Cells (CTCs) 2. Circulating Tumor DNA (ctDNA) 3. Extracellular Vesciles 4. Others
The POC data management software market was valued at USD 5916.9 million in 2019, and it is expected to reach a value of USD 11,772.2 million by 2025, registering a CAGR of 12.3% over the forecast period from 2020 to 2025. Point-of-care technologies enable hospitals and clinics to invest more time and money in technologies that help accelerate...
Brain Tumor Diagnostics Market Report Overview Brain Tumor Diagnostics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Brain Tumor Diagnostics market types and applications. It is a focused study on Brain Tumor Diagnostics market space...
Helicobacter Pylori Diagnostics Market Report Overview Helicobacter Pylori Diagnostics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Helicobacter Pylori Diagnostics market types and applications. It is a focused study on Helicobacter...
The Global Particle Counters Market is poised to grow at a CAGR of around XX% over the next decade to reach approximately $XX million by 2028. Some of the prominent trends that the market is witnessing include technological advancements in particle counters, increasing investments into research and development activities,...
The Global Precision Ball Screw Market is poised to grow at a CAGR of around XX% over the next decade to reach approximately $XX million by 2028. Some of the prominent trends that the market is witnessing include surge in medical diagnostics industry , rising demand for precision ball screws in semiconductor, aviation...
Summary Biocartis Group NV (Biocartis) operates as a molecular diagnostics company that provides personalized medicine for patients through its molecular diagnostics.The company undertakes the development of diagnostics technology platforms for multiplexed detection of bio-analytes, with oncology as its key focus area. Its...
Good genes: Improved technology and declining costs will likely foster industry revenue growth Abstract DNA & DNA Forensic Laboratories Over the past five years, the DNA and DNA Forensic Laboratories industry has benefited from improved accessibility and declining prices, which have made DNA testing...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global COVID-19 Diagnostics Market Report
The global COVID-19 diagnostics market by revenue is expected to register a negative CAGR of (9%) during the period 2021–2026.
The RT-PCR testing segment constituted over 75% of the global COVID...
158 pages •
By Global Industry Analysts
• Sep 2020
Global Preimplantation Genetic Diagnosis (PGD) Market to Reach $135 Million by 2027
Amid the COVID-19 crisis, the global market for Preimplantation Genetic Diagnosis (PGD) estimated at US$96.4 Million in the year 2020, is projected to reach a revised size of US$135 Million by 2027, growing at a CAGR of 4.9% over the analysis period...
Traditional aggregometer work on the principle of light transmission. The traditional aggregometer performs light transmission aggregometry (LTA) which was once considered as the gold standard for platelet function testing and is still used for the identification and diagnosis of platelet function defects. Traditional LTA remains the most...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.